Literature DB >> 21483895

Comparison of three-implant-supported fixed dentures and two-implant-retained overdentures in the edentulous mandible: a pilot study of treatment efficacy and patient satisfaction.

Ingeborg J De Kok1, Kuang-Han Chang, Tsui-Shan Lu, Lyndon F Cooper.   

Abstract

PURPOSE: The mandibular two-implant overdenture has been shown to be a highly successful treatment. However, overdenture patients who desire a fixed prosthesis may not be satisfied with a removable overdenture. This prospective study sought to compare prosthetic outcomes, patient satisfaction, and survival rates of implants between two-implant-supported overdentures (IODs) and three-implant-supported fixed dentures (ISFDs).
MATERIALS AND METHODS: Twenty completely edentulous patients were randomly and equally assigned to two groups. New conventional complete dentures were made, and the mandibular denture was used as a surgical guide during implant placement. Implants were placed in one stage, followed by a mandibular denture soft reline (provisional loading). Ball attachments were inserted at 8 weeks, and ISFDs were delivered at 16 weeks. IODs were connected to the attachments at 8 weeks, using each patients's existing denture. The definitive ISFDs were fabricated using computer-aided design/computer-assisted manufacture milled titanium frameworks and acrylic resin base and teeth. Patient satisfaction and panoramic radiographs were investigated at 6 and 12 months.
RESULTS: Both treatments had significant and positive effects on patient satisfaction and quality of life. None of the 50 implants placed had failed at 12 months of follow-up; therefore, the implant survival rate was 100%. Prosthetic complications were generally rare and easily manageable.
CONCLUSIONS: Both the treatment modalities-the ISFD supported by three implants and the IOD supported by two implants-significantly and similarly improved patient satisfaction and oral health-related quality of life, and prosthetic complications were relatively rare for both treatments. Three implants can be used to support a mandibular fixed prosthesis; however, a longer observation period is needed to validate this treatment modality.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21483895

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Implants        ISSN: 0882-2786            Impact factor:   2.804


  6 in total

Review 1.  The use of three implants to support a fixed prosthesis in the management of the edentulous mandible: a systematic review.

Authors:  Murtaza Hirani; Maria Devine; Olamide Obisesan; Cathy Bryant
Journal:  Int J Implant Dent       Date:  2022-06-17

Review 2.  Unsplinted Attachments and Patient-Reported Outcome Measures (PROMs) in 2-Implant-Retained Mandibular Overdentures: A Systematic Review.

Authors:  Pravinkumar G Patil; Liang Lin Seow; Ting Jing Kweh; Smita Nimbalkar
Journal:  Int J Dent       Date:  2022-05-24

3.  A comparative evaluation of fatigue resistance of two different implant overdenture stud attachments with two different denture base materials: An in vitro study.

Authors:  Namrata Agrawal; Sumeet Jain; Deepak Agrawal
Journal:  J Indian Prosthodont Soc       Date:  2018 Jan-Mar

4.  Success rate in implant-supported overdenture and implant-supported fixed denture in cleft lip and palate patients.

Authors:  Jaine Zanolla; Flávio Monteiro Amado; Willian Saranholi da Silva; Bruno Ayub; Ana Lúcia Pompéia Fraga de Almeida; Simone Soares
Journal:  Ann Maxillofac Surg       Date:  2016 Jul-Dec

5.  Comparing the Quality of Life of Patients Requesting Dental Implants Before and After Implant.

Authors:  Naser Sargozaie; Amir Moeintaghavi; Hamid Shojaie
Journal:  Open Dent J       Date:  2017-08-31

6.  Evaluation of Quality of Life and Satisfaction in Patients with Fixed Prostheses on Zygomatic Implants Compared with the All-on-Four Concept: A Prospective Randomized Clinical Study.

Authors:  Juan Alberto Fernández-Ruiz; Mariano Sánchez-Siles; Yolanda Guerrero-Sánchez; Jesús Pato-Mourelo; Fabio Camacho-Alonso
Journal:  Int J Environ Res Public Health       Date:  2021-03-25       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.